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Foreword 
This report is the first of a new series of publications reviewing the 
Quality of Health Care across selected OECD countries. As health costs 
continue to climb, policy makers increasingly face the challenge of ensuring 
that substantial spending on health is delivering value for money. At the 
same time, concerns about patients occasionally receiving poor quality 
health care has led to demands for greater transparency and accountability. 
Despite this, there is still considerable uncertainty over which policies work 
best in delivering health care that is safe, effective and provides a good 
patient experience, and which quality-improvement strategies can help 
deliver the best care at the least cost. OECD Health Care Quality Reviews 
seek to highlight and support the development of better policies to improve 
quality in health care, to help ensure that the substantial resources devoted to 
health are being used effectively in supporting people to live healthier lives. 
Korea is an ideal place to start this new series. Few countries have had 
as remarkable an expansion in health coverage over the past three decades. 
That Korea has achieved this at modest costs relative to other OECD 
countries is all the more remarkable. However, it is for the magnitude of its 
looming challenges – an ageing population, rapidly rising costs and growing 
chronic disease burden – that Korea is now pursuing further reforms. The 
challenges that Korea faces are common to many OECD countries, and will 
demand that policy makers re-orient health care to prioritise quality while 
containing costs. This report seeks to provide constructive advice to further 
these efforts, informed by the experience of OECD countries at large. 
This report on Korea was managed and coordinated by Ankit Kumar. 
The other authors of this report are, in alphabetical order, Gerrard Abi-Aad, 
Y-Ling Chi and Niek Klazinga.  The authors wish to thank John Martin, 
Stefano Scarpetta, Mark Pearson, Francesca Colombo and Michael Borowitz 
from the OECD Secretariat for their comments and suggestions. Thanks also 
go to Marlène Mohier and Lucy Hulett for their tireless efforts on editing, 
and to Judy Zinemann for assistance.  
The completion of this report would not have been possible without the 
generous support of Korean authorities. This report has benefited from the 
expertise and material received from many health officials, health 
professionals, and health experts that the OECD Review team met during a 
mission to Korea in May 2011. These included officials from different 
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national offices and agencies, in particular: the Ministry of Health and 
Welfare, the Health Insurance Review Agency (HIRA), the National Health 
Insurance Corporation (NHIC) and National Evidence-based Healthcare 
Collaborating Agency (NEHCA). The authors would also like to express 
their gratitude to professional organisations such as the Korean Hospitals 
Association, the Korean Medical Association and the Korean Nursing 
Association; and to the many academics, health professionals and consumer 
representatives that shared their perspectives on improving quality of care in 
Korea. The Review team is especially thankful to Dr Min Soo Park 
(Ministry of Health and Welfare) and Dr Sun Min Kim at HIRA for their 
help in preparing the mission and co-ordinating responses to an extensive 
questionnaire on Quality of Care policies and data. The report benefited 
from the invaluable comments of many Korean authorities and experts who 
reviewed an earlier draft of the report.  
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Executive summary 
This report reviews the quality of health care in the Korean health 
system. It begins by providing an overview of the range of policies and 
practices and the role they play in supporting quality of care in Korea today 
(Chapter 1). It then focuses on three key areas: using health financing to 
drive improvements in the quality of health care (Chapter 2), strengthening 
primary care in Korea (Chapter 3), and improving care for cardio-vascular 
diseases (Chapter 4). In examining these areas, this report seeks to highlight 
best practices and provide recommendations to improve the quality of health 
care in Korea.  
Within less than 30 years, Korea has gone from having a limited 
medical infrastructure and a fragmented health financing system with 
several insurance schemes covering a relatively small share of the 
population to establishing a health care system characterised by universal 
coverage and substantial acute medical facilities. Even after achieving 
universal coverage in 1989, the pace of reform in the Korean health system 
has not slowed. At the turn of the century, the functions of prescribing and 
dispending of pharmaceuticals were separated (the former to doctors and the 
latter to pharmacists), and the large number of autonomous insurance 
societies were consolidated into a single national insurer. A legacy of this 
continuous period of ongoing change is that efforts to improve the quality of 
care are not embedded in the Korean health system. At the provider level, 
quality of care is often driven by motivated individuals that choose to 
prioritise this. At the national level, policy makers have an institutional 
architecture that allows them to improve the quality of care, but often 
struggle to prioritise this over other objectives.  
The Korean health system needs to shift its focus from an ever-
continuing expansion of acute services to be prepared to deal with the rapid 
population ageing that Korea has begun experiencing and the rising 
incidence of chronic diseases. The financial starting point for dealing with 
these challenges makes health care reform in Korea all the more necessary: 
Korea is already experiencing growth in health care expenditure per capita 
that is amongst the fastest in the OECD, and double the average of OECD 
countries over the past decade. More spending does not necessarily lead to 
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higher quality. Indeed the opposite is possible - where the likely over-
provision of health services to patients by Korea‟s hospitals today is a 
significant concern for the quality of care. Policy makers should seek to 
introduce payment systems that encourage an appropriate amount of care 
being delivered to individual patients when they visit a hospital. These 
reforms ought to be combined with greater control of the overall budget for 
hospitals. In this way, policy makers can influence where money is spent, 
and channel spending growth to more cost-effective services beyond 
hospital doors. This will help patients avoid hospital admissions (or re-
admissions) in the first place. The single insurer is Korea‟s foremost 
institutional strength in achieving these reforms to improve quality, but 
doing so will require Korea‟s single insurer to become a proactive purchaser 
and not simply a passive payor.  
The key policy priority for improving the quality of care in Korea 
should be the development of a strong primary care sector. This will be 
critical to ensuring that the Korean health care system can support patients 
in coordinating their ongoing health needs across multiple health services 
and to help them undertake actions to moderate the risk of their condition. 
This will require investments to scale up the primary care sector – for 
example, by supporting the expansion of successful models of care, and 
higher remuneration for cost-effective patient services such as patient 
counselling and lifestyle modification. A stronger primary care sector will 
also require a larger, dedicated workforce of primary care professionals. 
These investments will need to be consistent with developing strong primary 
care institutions in the long term. At the most immediate level, best practice 
from OECD countries suggest that group practice can help improve the 
quality and coordination of care. These practices ought to be supported by 
regional institutions – which can provide the means for the insurer to 
channel specific resources to those communities most at need. To inform 
this, Korea will need better measures of quality of care along regional 
boundaries.  
There is also considerable scope for targeted and high-impact initiatives 
to deliver improvements in the quality of care today. The most pressing is to 
develop better systems to monitor individual clinician performance, which 
can identify breaches in patient safety and provide a means for patients to 
provide feedback on the quality of care they experienced. This ought to be 
complemented with greater efforts to encourage clinicians to keep their 
skills up-to-date through continuing education. Korea already has a best 
practice system for hospital accreditation, but too few hospitals are being 
accredited. Efforts to extend the scope of accreditation beyond hospitals are 
commendable, and would be further enhanced by extending accreditation to 
primary care. Similarly, Korea has world class information technology, as 
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demonstrated in its Drug Utilisation Review. However, the application of 
this information infrastructure ought to be extended beyond 
pharmaceuticals. Patient histories should be made available (within a 
privacy framework) to help providers improve the appropriateness of the 
care they provide.  
The various strengths and areas for improving the quality of care across 
the Korean health system at large are mirrored in the quality of care for 
cardiovascular conditions. While variations exist across the country, Korea‟s 
hospital sector delivers high quality cardiovascular care. This is likely to be 
the consequence of policies for cardiovascular care that reflect the same 
hospital-focused approach to health policy that Korea has for the system as a 
whole. The focus for the future ought to be outside hospitals: by preventing 
cardiovascular conditions through modifying risky behaviours, helping 
patients manage their condition before they are admitted to hospital, 
improving ambulance services and providing comprehensive rehabilitation 
to support recovery.   
By pursuing a combination of policy reforms at a system-wide level and 
targeted reforms to address particular shortfalls, there is considerable scope 
to improve the quality of care in the Korean health system. This report 
contains the OECD‟s recommendations to help Korea do so.  
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Assessment and recommendations 
Introduction 
Korea has undergone a remarkable increase in economic and human 
development over the past three decades. Rising standards of living have been 
accompanied by major improvements in the availability of health care 
services, underpinned by the rapid expansion of health insurance coverage. 
Remarkably, Korea today combines one of the highest life expectancies in the 
world with one of the lowest levels of health care expenditure amongst OECD 
countries (6.9% of GDP in 2009). Hospitals are more likely to be available, 
and equipped with cutting-edge medical technologies, than in most other 
OECD countries. Two decades of pursuing reform has not only expanded 
coverage but also delivered administrative savings through the consolidation 
of insurers under the publically-owned National Health Insurance 
Corporation. The development of the Korean health system over the past two 
decades serves as a model for countries seeking to deliver universal coverage 
for health care through social insurance at a reasonable cost. 
Having now consolidated its achievements, Korea‟s health care system 
needs to shift its focus from simply supporting an ever-continuing expansion 
of acute care services. A health system operated along these lines will not be 
well prepared for the challenge of chronic diseases and disabilities that will 
come with Korea‟s wealthier and older population. Recent lifestyle changes, 
such as a shift towards more western diets, have resulted in a steady increase 
in the fat intake and increases in obesity levels (albeit from a low level). 
While low compared with other OECD countries, alcohol consumption is 
increasing. Smoking rates remain persistently high, with more Korean men 
smoking on a daily basis than in all OECD countries other than Turkey and 
Greece. These indicators of risky behaviours foreshadow the twin challenges 
of chronic disease and ageing that will continue to compound pressure on 
the health system. Health spending per capita in Korea has already been 
growing at nearly 8% a year since 2002 – the fastest amongst OECD 
countries and more than double the OECD average of 3.6% a year over the 
same period. Korean policy makers face a considerable challenge: continued 
increases in spending at these rates of growth are clearly unsustainable. Yet 
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maintaining a system that is focused on acute care will only perpetuate high 
growth in health care spending. 
Despite the rapid increase in investment and physical resources that 
Korea has experienced over the past years, it is not evident that the system is 
delivering proportionately higher quality care. Korea has some of the 
highest rates of potentially avoidable hospital admissions for the common 
respiratory conditions of asthma and chronic obstructive pulmonary disease 
(COPD). Similarly, admissions to hospitals of people suffering from high 
blood pressure (a potentially manageable condition) have increased steadily 
in recent years to now be the fourth highest amongst OECD countries. 
Within hospitals, the proportion of people who die within 30 days of being 
admitted into hospital for acute myocardial infarction in Korea is the highest 
amongst OECD countries. More generally, once admitted to hospital for 
inpatient care, a Korean patient is likely to remain there for more than twice 
as long as the average of nine days across OECD countries. These relatively 
poor outcomes are likely to reflect that Korea has had considerable policy 
challenges, and focused its efforts over past years on expanding coverage 
and reducing out-of-pocket costs. Looking ahead, the major challenge for 
Korea‟s health care system over the next decade should be to make quality 
of care and value for money the operating principles for health policy.  
Quality of care policies in Korea are patchy. This is reflected in three 
core challenges for improving the quality of care that consistently recur 
throughout this report: 
 Korea does not have a strong community-based primary-care 
system. As a result, consumer preferences to seek out hospital care 
are reinforced by a fiercely competitive market of health care 
providers who, too often, deliver what is possible for them and not 
what is most appropriate for patients‟ long-term health.  
 Governance of the health system does not sufficiently reinforce 
quality of care as a key priority. Policies to monitor and improve the 
performance of the system are often taken up unevenly across health 
care providers, and pockets of excellence are often driven by the 
initiatives of select providers and institutions. 
 The health system does not make the most of the data available to it. 
Korea has the information technology infrastructure and data to help 
map shortfalls in performance and assess what works well and what 
does not. This information should be judiciously deployed to direct 
funding to areas that deliver high value for money and respond to 
health needs.  
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Notwithstanding these concerns, Korea‟s substantial health reforms to 
date have equipped it with an ideal institutional architecture from which to 
pursue further reforms. The single insurer provides Korea with the ability to 
use its monopoly purchasing power to drive improvements in quality of 
health care. Equipped with better financing instruments, the single insurer 
could be harnessed to gradually improve the structure of health services in 
Korea to better meet the changing health care needs of its population. Doing 
so will be necessary to support Koreans more effectively as they live longer 
and more often, with multiple chronic diseases.  
More immediately, Korea‟s National Health Insurance is facing the 
prospect of further deficits. This creates a unique window of opportunity for 
further reform. As with many other OECD countries, reform will need to be 
undertaken while government grapples with tight fiscal circumstances. This 
situation will be compounded by an ageing population and shrinking 
workforce. This report argues that prudent reforms are desirable, and that 
leveraging improvements in the quality of care ought to be a key objective. 
It seeks to highlight good practices and make recommendations on how 
further improvements can be made in the quality of care.  
Effort is needed to strengthen the focus of governance on quality of care  
Korea‟s quality of care policies have too often relied on motivated 
individuals and institutions to build pockets of excellence within the Korean 
health system. Too often, these individuals and institutions do not seem to 
work within a system whose governance demanded best practice or sought 
to disseminate it across the system. The Korean approach towards health 
care system governance is often grounded in the policy mindset of industry 
development: it encourages the growth of providers and competition 
amongst them, but often lacks the same focus on delivering broader social 
objectives which characterise insurance-based health systems across OECD 
countries. The focus of the health system is on product quality and less on 
system quality – each individual task may be done well, but they may not be 
the best choice of tasks, given the problems being addressed.  
Encouraging a system-wide focus on improving the quality of care 
should begin with changing the focus of governance from reimbursing 
medical services to improving peoples‟ health. Korea could achieve this by 
broadening the current legal framework and creating an institutional 
„champion for quality‟. The current legal framework for health care in Korea 
centres around assuring the delivery of insured services. This is a narrower 
scope than the significant majority of OECD countries who locate 
governmental responsibility for the broader objective of protecting (and 
often improving) their citizens‟ health within their constitutions or key 
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health legislation. The most immediate implication of this is that 
responsibility for quality assurance of the significant amount of health care 
delivered outside of the basic insurance basket is not clear. A further 
consequence of this approach is reflected in the operations of Korea‟s 
Health Insurance Review Agency (HIRA), whose role today centres around 
quality assurance and auditing of claims for publicly reimbursed medical 
services.  
There is scope for HIRA to play an expanded role and drive quality 
improvement for all services, not just those covered under insurance. This 
will require a sustained effort to change the culture of providers in the 
Korean health system to prioritise quality of care in their work. HIRA ought 
to take the lead on this: by providing feedback to individual providers and 
judiciously publishing information on the quality of care, HIRA should seek 
to establish itself as a champion for quality improvement across the system 
at large. This would build on HIRA‟s current responsibilities for evidence-
based medicine (in collaboration with the National Evidence-based 
Medicine Collaboration Agency) and its loose links with organisations for 
health technology assessment and evaluating pharmaceuticals. Legislation to 
enforce such a framework for governing health care quality in Korea would 
be worthwhile. 
Good policies for quality of care exist – especially in the hospital 
sector– but without monitoring of the quality of individual clinician 
performance, have less impact than they should 
While both medical and hospitals associations have developed processes 
for hospital accreditation and clinical education, self-regulation of individual 
clinician practice is weak. Medical education and in-hospital training 
programmes for new doctors provide the bedrock of assuring quality of care 
in Korea. This is supported by a programme of continuing education 
provided by the respective medical and nursing professional bodies. Recent 
policy efforts by the Ministry of Health to seek the re-certification of 
medical professionals to improve continuing education completion rates and 
strengthen licensing are a welcome step to further improve the quality of 
care provided in Korea. 
Perhaps the most alarming feature of the Korean health system is the 
lack of clear mechanisms to assure patient safety. Over the past two decades, 
health systems across OECD countries have sought to monitor individual 
clinician performance in order to identify undesirable trends in clinical 
practice and mitigate the situation. Such systems monitor breaches in patient 
safety (such as sentinel events) and provide a means for patients to deliver 
feedback on their experience of health care services (including on matters 
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relating to quality). Efforts ought to be undertaken to build a comparable 
system in Korea as part of a national programme on patient safety. This 
could build on some existing quality assurance mechanisms where 
individual hospitals have instituted their own procedures.  
Such systems for patient safety typically have feedback mechanisms to 
assist medical associations in maintaining professional standards. Across 
OECD countries, medical associations often play an important self-
regulatory role in investigating serious quality breaches and cases of 
potential professional misconduct, and if necessary, move to de-register a 
medical professional. It would be worthwhile for medical professional 
bodies in Korea to learn from the processes and systems that the Korean 
Nursing Association has put in place. There is a strong case for government 
to establish a mechanism to investigate such matters if medical professional 
bodies do not do so. A lack of action in this area will likely lead to strong 
growth in medical malpractice-related legal disputes. Already, these are 
estimated to cost 1% of health expenditure, growing at a rate of 15% a year.  
As with most OECD countries, Korea has had a longstanding hospital 
accreditation programme that has seen some reforms in recent years. While 
Korea‟s new accreditation process is rigorous, it is not applied broadly 
enough within the hospitals sector and is only beginning to extend beyond it. 
Modelled after programmes in the United States, Chinese Taipei, and 
Australia, Korea‟s hospital accreditation process covers a large number of 
areas. It also pursues the worthwhile approach of using accreditation to 
enable it to act as a quality improvement partner with hospitals. However, at 
the end of 2011, accreditations undertaken to date have covered the forty-
four tertiary hospitals but only 12% of general hospitals (33 hospitals) and 
0.6% of small hospitals (8 hospitals). While this may in part reflect the 
infancy of the new arrangements, the change from mandatory to voluntary 
accreditation has weakened its role as a strategy for quality assurance, 
particularly in the small and medium hospitals where accreditation is most 
needed. Accreditation ought to be linked to financing to provide the 
necessary pressure on more small and general hospitals to seek 
accreditation. Recent efforts to expand the scope of accreditation to include 
long-term care hospitals and psychiatric hospitals from 2013 are 
commendable. Beyond this, accreditation should also be extended to 
primary care facilities in order to institute a focus on quality throughout 
Korea‟s health care facilities. 
A range of other policies can also be strengthened to improve quality of 
care. In recent years, Korea has sought to boost its capacity to develop 
clinical practice guidelines. One programme is run through the Korean 
Academy of Sciences. The other is government-sponsored and operates 
through clinical research streams. These programmes have usually been led 
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by specialist research groups on different topics. While there is significant 
work being undertaken with research institutes and the National Evidence-
based Health Care Collaborating Agency (NECA), the extent to which this 
is influencing clinical practice or decisions on financing care is limited. 
Establishing a process by which such agencies could feed into financing 
decisions and inform clinical standards would be a desirable development.  
Korea has world-class information technology infrastructure and 
health care data – these should be harnessed to improve quality and 
drive policy 
Korea has overcome many of the challenges other OECD countries have 
faced in recent years to build a world-leading health information technology 
infrastructure. In particular, Korea‟s Drug Utilisation Review is one of the 
most extensive systems for monitoring prescribing to be found amongst 
OECD countries. This system uses an individual identifier to check for when 
a patient has been provided with a drug that is likely to conflict or overlap 
with medications they are currently using. The system undertakes these tests 
both when drugs are prescribed at clinics and when sold at pharmacies. 
However, despite the substantial investment in advanced technological 
infrastructure to put this system in place, the system seeks to identify 
incompatibilities in the chemical composition of drugs rather than 
incompatibilities in the therapeutic function of drugs prescribed (the latter 
provides more scope to identify situations of unnecessary prescribing and 
pre-empt medication mis-management). Narrowing the scope of such a 
system unnecessarily constrains its potential impact, and efforts ought to be 
undertaken to make the most of this technology which exceeds in breadth 
and depth any other system in the world. Similarly, the eventual extension of 
this system to include major hospitals would be worthwhile in helping 
manage medication management issues and reduce costs. 
More value can be extracted from data already available to HIRA. By 
linking claims information, quality indicators for clinical care and 
information available in registries, Korea could better analyse the 
performance of the health care system and tailor care to specific needs. For 
example, Korea currently has the capability to “follow” patients with multi-
morbidities or those suffering from chronic health conditions to better 
understand which health care services they are using, how often, and their 
readmission and mortality prospects. The knowledge garnered from such 
monitoring could inform what services are best delivered to patients as a 
follow up to one of Korea‟s health-care screening programmes. Similarly, 
better information would be indispensible for improving the quality of 
cancer care, where registries could follow various cohorts of patients, their 
treatment outcomes and their mortality. The carefully orchestrated use of 
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data on patient outcomes and services could also be used to provide 
regional-level information – and help policy makers and consumers 
determine if the right (and enough) resources are being directed to those 
areas most at need.  
Korea already has the technological capability to build a simple 
electronic patient history, and should do so. Individual patient identifiers 
form the basis of the Drug Utilisation Review and are recorded in claims 
services reimbursed under health insurance. This system for electronic 
recording of patient identifiers could form the backbone of a simple 
electronic patient history that records information on a person‟s medications 
and previous use of health services. In time, this could be extended to 
include electronic storing of diagnostic and other test results, potentially 
helping reduce the cost of duplicate services in the system today. There is a 
reluctance to undertake further efforts in this direction in Korea due to 
privacy concerns. Korea should look to efforts being undertaken in other 
OECD countries to accommodate privacy concerns, as this technology can 
deliver a considerable payoff in helping doctors improve the quality and 
appropriateness of the care they provide.  
Improving the quality of information about what is being delivered in 
Korea‟s hospitals sector and how much hospitals are earning will help 
ensure that financing decisions are better informed. Systems already exist 
within hospitals today which separate services into those that are reimbursed 
by insurance and those that are paid directly by consumers. Government is 
not currently informed about the extent of the latter, and receiving this 
information could help national health insurance agencies understand the 
extent of utilisation of new technologies in the health system. As a longer 
term ambition, it would provide a means to determine the extent to which 
licensing of certain high-technology medical equipment – as is undertaken 
in France, the United Kingdom, Canada and Australia – ought to be 
considered to encourage appropriate utilisation and reduce costs. At the 
same time, improved financial reporting by hospitals would provide an 
indication of their operational challenges and what their cost pressures are. 
When combined with information available within government on public 
subsidies provided to these hospitals for the delivery of insured services, this 
could provide much-needed transparency on the extent to which hospitals 
raise revenues from sources outside of funds from public insurance. Given 
the substantial public investment in the hospitals sector, seeking further 
financial transparency is not an unreasonable expectation and should be 
made obligatory as a condition of insurance payments. 
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Strengthening primary health care in Korea 
Tackling chronic diseases demands better primary-care services to 
help patients get appropriate care 
Korea‟s rapid economic development, emerging lifestyle risk factors 
and ageing population will increase the prevalence of chronic diseases in the 
future. Korea has one of the fastest growing elderly populations and the 
lowest birth rates amongst OECD countries. At the same time, too many 
Koreans are presenting at hospitals for conditions that could have potentially 
been avoided. In 2009, there were around 326 000 admissions for 
hypertension, angina, diabetes, heart failure, COPD and asthma. Compared 
with other OECD countries, Korea ranks amongst the highest for potentially 
preventable admissions relating to COPD, asthma and uncontrolled diabetes. 
These unnecessary episodes, and the health care costs they incur, underline 
the need for targeted actions to ensure that chronic disease is properly 
managed within the community setting.  
As is the case in many other OECD countries, older and poorer patients 
seeking Korea‟s health services are more likely to be living with more than 
one health condition and are likely to require care that straddles multiple 
health services and specialists. Dealing with such cases effectively demands 
better co-ordination of their care and support to help them undertake actions 
to help moderate the risk of their condition. The Korean health care system 
will need to adapt to support patients in co-ordinating their health needs 
across the multiple specialist services they may rely on, and ensure good 
continuity of care. Critically, it will need to help patients avoid acute care 
except where necessary. Currently, the system does the opposite – it 
encourages further diagnosis and the utilisation of the large hospital sector. 
This is medically undesirable, unnecessary, and expensive. A reliance on 
hospitals is exacerbated by a long-standing tradition of health-seeking 
behaviour which places a greater value on hospital-based care. Over-
provision of treatment is a major quality of care issue in Korea.  
Developing primary care must be the major investment priority for 
Korea’s health system 
Korea‟s community-based family medicine sector is woefully 
underdeveloped today. There is a need to shift away from the current 
version of “primary care” as a gateway to more complex surgical or medical 
procedures and towards the provision of evidence-based health promotion 
and prevention along with partnering with patients to help them select the 
appropriate services for their needs. Current remuneration levels make it 
hard to do this, making the practice of family medicine unattractive while 
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supporting the oversupply of other services with greater complexity. As a 
result, primary care providers feel a financial pull towards becoming mini-
hospitals that provide surgical procedures, often when not appropriate or 
safe. Correcting this situation will require ongoing investment, specifically 
for primary care and preventative health services. 
The bulk of this investment should be directed towards supporting the 
scaling up of effective models of primary care. A number of small-scale 
initiatives and demonstration projects that accord with best-practice models 
of primary care currently exist in Korea today, but they lack the financial 
support and the institutional backing to expand across the country at large. 
The critical characteristics which successful projects have in common 
include: a community focus, patient registration backed by financial support, 
outreach preventive services, continuity of care, patient follow up and 
information exchange with HIRA and the NHI. Many of these features 
figure prominently in OECD countries with strong primary care systems. A 
good example of a community programme is the Gwang Myeong 
registration project which focuses on diabetes and hypertension management 
(profiled in Chapter 3). 
The broader development of such services could be supported by 
domestic policy makers specifying “best-practice characteristics” and 
financially supporting regional providers who can deliver services that 
accord with these characteristics in meeting local health needs. Such a 
policy should also be used to encourage the development of group practice 
amongst Korea‟s 26 000 solo practitioners, making it easier for them to 
undertake care coordination and peer review. Where useful and appropriate, 
such an approach should build on existing infrastructure supporting 
mandatory coverage of screening services in communities across Korea – in 
essence, becoming “follow-up” services for patients with identified health 
needs. Over the long term, this will help establish a regional architecture for 
primary care that National Health Insurance agencies can use to identify and 
direct funding to areas most in need. 
Strengthening primary care requires better information and 
increased efforts to build a primary care workforce  
Encouraging controlled and appropriate referrals by primary care 
professionals could help reduce the over-utilisation of hospital services. 
Many OECD countries rely upon family doctors to help direct patients 
towards appropriate services – whether it be specialist care in a hospital or 
allied health services. While there is notionally a requirement to have a 
referral from a family medicine specialist or a general medical practitioner 
prior to visiting a medical specialist, gate-keeping in Korea is not enforced 
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strictly and patients can access acute services with relative ease. Many 
hospitals have also adopted practices such as establishing family medicine 
centres (or departments) on hospitals premises that could sometimes also 
serve as a “gateway” for patients into the hospital at large. Engendering a 
culture of controlled and appropriate referrals is a complex and long-term 
challenge for the Korean health system that will require a combination of 
better information, a better understanding of the value of primary care 
amongst health professionals, greater financial investment and a shift in 
remuneration practices.  
The use of existing data to develop better measures of quality of care in 
primary care could be a useful tool to guide policy development and 
funding. The development of primary care quality measures will facilitate 
analysis of quality trends and will provide the information base for remedial 
action. Within its expansive data infrastructure, HIRA currently has the 
ability to monitor the number and type of patients presenting at hospitals 
with potentially preventable admissions. Such information could be 
invaluable in identifying areas where primary care services are not 
encouraging controlled and appropriate referrals. Similarly, HIRA is able to 
monitor the utilisation of ambulatory care in emergency departments. In 
pharmaceuticals, HIRA is able to monitor the prescribing of antibiotics, 
drugs of limited clinical value and the ratio of generic to branded drugs – 
information that could help map where quality shortfalls are occurring (and 
where unnecessary costs to the system are being incurred). Critically, HIRA 
has the ability to map the geographical differences in performance across 
Korea. Doing so along the lines of regional boundaries that align with the 
scaling up of primary care services (as recommended above) will provide 
National Health Insurance agencies with the tools to make regional 
assessments of needs or identify where shortfalls may be occurring. Such 
information could bring into focus the often higher needs and fewer 
resources in rural communities. More broadly, these indicators can bring the 
benefits of primary care into sharper relief and foster a culture of delivering 
higher quality care.  
Efforts to develop a workforce of primary health care professionals will 
be essential to developing a stronger primary care system. The majority of 
new medical graduates in Korea currently prefer to gain a specialisation and 
often undertake most of their training in hospital-based settings. At the same 
time, independent medical professionals working in primary care often feel 
the need to deliver basic surgical and inpatient services to maintain their 
viability. While investment and a more pronounced role in the health system 
would help enhance the professional status of family physicians, Korea also 
needs to engender an awareness of the importance of primary care amongst 
its medical profession. Providing more medical students with the experience 
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of working in primary care could help impart an understanding of the role 
and importance of primary care. Policy makers should work with medical 
associations and universities to introduce a mandatory training rotation in a 
primary care facility. Such a programme (of limited duration) could build on 
existing training opportunities available in select schools. Critically, it 
would also help bolster the size of the primary care workforce, especially in 
rural areas where the number of community-based health professionals has 
been steadily reducing. Providing a modest training subsidy would support 
the development of a training culture in primary care practices across the 
country. At the same time, more immediate changes could be driven by 
further promoting advanced practice nurses, who could play a valuable role 
in supporting physicians‟ delivery of preventive health care, reviewing 
people at risk of developing chronic disease and planning coordinating care 
for patients with complex health care needs. 
Using financing to drive improvements in quality of care 
The significant hospitals sector is driving growth in health spending 
Hospitals accounted for nearly half of all additional expenditure in 
Korea over the past decade. This is significantly more than in other OECD 
countries where hospitals accounted for around one third of additional health 
expenditure. Whether measured by the number of hospitals, beds or high-
technology medical equipment, for the size of its population, Korea has one 
of the most substantial hospital sectors amongst OECD countries today. 
In part, this reflects the fact that payments for health services that are not 
efficient and do not reward quality of care. Korea‟s fee-for-service payments 
reward doctors for delivering ever more complex care, but often at lower 
unit fees per service compared with many OECD countries. This is 
compounded by a fiercely competitive private market for delivering health 
care services. As providers have sought to compete by increasing volumes, 
complexity or delivering services outside the health insurance benefit basket 
(where prices are unregulated), the boundaries between services delivered in 
small doctors‟ clinics and in hospital outpatient departments have become 
increasingly blurred. This has come at the expense of properly funding 
community-based primary health care services. Within this market structure, 
doctors in Korea have to balance the desire to provide appropriate care with 
the need to generate revenue. The result is often higher costs. For example, 
this is reflected in Korea‟s exceptionally high lengths of stay for hospital 
inpatient services, which along with Japan are more than double the OECD 
average and significantly higher than the next highest country. A major 
challenge for financing is to build better incentives for appropriate care.  
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In a difficult budgetary environment, tackling burgeoning acute 
care services will improve quality and reduce costs 
Quality can be improved and costs can be contained by reversing the 
incentives for over-provision and over-supply of hospital services. Hospital 
financing reforms have had a difficult history in recent years as Korea has 
sought to shift to paying a benchmark price per “case” delivered in a 
hospital (diagnosis-related groups, DRGs). DRGs reward service providers 
who are more efficient than the benchmark price and provide all with an 
incentive to moderate costs. After substantial negotiations, the current 
Korean DRG scheme was established and covers a handful of clinical 
categories. However, the non-participation of tertiary hospitals in this 
scheme has weakened its potential to drive quality and efficiency. DRGs 
ought to be introduced across the entire Korean hospitals sector to introduce 
price signals that encourage an appropriate amount of care per case – a focus 
that Korea‟s hospitals‟ lack today. 
These reforms to hospital financing should be complemented with better 
safety and quality monitoring. Other OECD health systems such as 
Australia, Canada, France and the United States with these forms of 
payments have sought to establish appropriate admissions and discharge 
criteria and close surveillance of the intensity and volume of services 
delivered. Some of these countries also use financing systems to improve 
data collection on the quality of care, such as through recording secondary 
conditions and flagging conditions that are present on a patient‟s admission 
to hospital. These measures would be worthwhile to collect even before a 
shift to DRG-based payment can be feasibly implemented in Korea. Indeed, 
while they have cited concerns over a deterioration in quality in resisting the 
introduction of DRGs, Korea‟s tertiary hospitals are more likely than 
general and smaller hospitals to have already instituted the kind of quality 
management programmes and checklists needed to monitor and correct 
perverse outcomes. The challenge for policy makers is to encourage the use 
of such systems in the large number of small and medium-sized hospitals, 
who are likely to have already opted into DRG-based payments. Such 
quality monitoring will provide the information architecture needed to 
incorporate quality into purchasing, which ought to be institutionalised by 
giving National Health Insurance agencies a greater mandate to vary 
payments to hospitals (or groups of hospitals) on the basis of achieving a 
certain level of quality performance or delivering services more efficiently. 
Shifting from the current system based on retrospective reimbursement 
based on fees set annually to a dynamic and ongoing process of negotiation 
offers Korea an opportunity to make the most of the purchasing power of its 
single insurer. 
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DRG-based financing could also be used to develop better macro 
budgetary controls and influence the balance of funding between acute and 
primary care over time. DRGs not only specify a set of relative prices 
between different types of health care services, but also provide the ability 
to adjust the overall level of prices, which can be an important lever in 
influencing overall spending for hospital services. Health systems that use 
DRGs in OECD countries often specify (or target) an overall budget for 
acute care services in the year ahead – based on forecasts of the mix and 
volume of services within a given year. This helps signal the government‟s 
overall appetite for outlays and helps manage the risk of providers 
increasing volumes. Within the institutional architecture of a single insurer, 
Korea is well placed to consider specifying an overall budget for acute 
hospitals. If budget overruns incur a credible penalty (such as no payment or 
discounted payment for services), such an approach could provide a system-
wide impetus for additional efficiency. As a longer term ambition, this could 
also be used to influence the allocation of funds between acute and primary 
care sectors in Korea.  
More appropriate care should begin with making primary care the 
core financing priority 
Driving more appropriate care will require National Health Insurance to 
shift the centre of financial gravity in the Korean health system from 
hospitals to primary care. With a single insurer, Korea is well positioned to 
use its purchasing power to drive improvements in the quality of care. 
However, health financing in Korea is currently embedded in the 
psychology and operational model of fee-for-service payments. For National 
Health Insurance to become more of a proactive purchaser – rather than a 
passive payor – this will need to change. National Health Insurance will 
need to develop the tools needed to direct funding for services to patients or 
areas most at need. This should be directed at effective primary care 
services, which hold the potential to provide care that is better suited to the 
rising population health challenge of people living with multiple chronic 
diseases, and potentially at a lower cost. 
To establish primary care as an institutional priority, investments to 
scale up primary care in Korea should become a distinct component of 
National Health Insurance expenditure. Policy makers ought to have the 
financial freedom to assess and invest in proposals that represent best value 
for money in delivering high-quality primary care. Locating funding within 
National Health Insurance would align new investments with the 
institutional imperative of reducing longer term payouts by the single 
insurer. This would build on current efforts to make the National Health 
Insurance more responsible for programmes to support the management of 
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patients with chronic disease. On a broader level, it would help foster an 
operating culture where the insurer is seen as a financial agent capable of 
delivering system change to improve quality of care, and not simply as a 
payment clearinghouse. In the same manner in which the gradual expansion 
of insurance helped underwrite the development of Korea‟s hospitals sector, 
the National Health Insurance should now be harnessed as a major source of 
financing for the development of a stronger primary care sector in Korea. 
Korean policy makers may wish to consider hypothecating a gradually 
increasing proportion of NHI revenues towards this purpose. On-going 
financial commitment will be critical to change the structure of health care 
service providers in Korea over time. 
Institutional reform of this nature is a long-term objective. In the 
immediate future, Korean policy makers should increase financial support 
for prevention and patient self-management of chronic disease. This will 
require developing an effective means of incentivising primary care 
professionals to derive a greater proportion of their income from the 
delivery of physician education and counselling, and reducing their reliance 
on minor surgical procedures, referrals for diagnostic tests and prescribing 
drugs as a source of income. A modest starting point for broader financing 
reform could be to address the structure of fee-for-service payments in 
Korea, which currently pay hospitals a premium per service delivered on the 
basis of their size (i.e. larger hospitals get paid more for the same service 
than smaller hospitals). This is a substantial outlay that rewards providers to 
pursue capacity expansion. Redirecting some of this investment towards 
rewarding hospitals – irrespective of their size – that deliver high-quality 
and appropriate services would deliver better value for money. At the same 
time, there exists scope for policy makers to pilot the use of “bundled 
payments” that prospectively combine payment for a hospital admission as 
well as a reasonable number of pre- and post-admission services. This could 
provide a financial incentive for hospitals to invest downstream, into less 
clinically intensive rehabilitation services and to substitute complex and 
acute care services with cheaper (and more appropriate) family-based 
medical care. 
Pay for performance in Korean hospitals has had moderately 
encouraging results, and may be usefully extended to targeted areas 
The introduction of a pay-for-performance scheme in Korea‟s 43 tertiary 
hospitals is one of the more innovative policies to use financing to drive 
improvements in quality of care across OECD countries. Korea‟s Value 
Incentive Programme targets improvements in two areas of comparatively 
poorer performance compared with other OECD countries: acute myocardial 
infarction and the proportion of caesarean deliveries. Hospitals participating 
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in the programme have improved acute myocardial infarction treatment 
performance and outcomes over the three years since the programme was 
established. Similarly, data indicate an observable reduction in caesarean 
sections. Most notably, data suggest that there has been a decrease in the 
variance in performance amongst hospitals and significant improvements 
amongst the lowest performing group.  
Absent a formal evaluation at this early stage, this targeted pay-for-
performance programme appears to be a useful way of collecting data and 
incentivising targeted improvements in the quality of care. The Value 
Incentive Programme benchmarks the relative improvements in performance 
of each of Korea‟s tertiary hospitals through collecting indicators associated 
with good clinical processes, the impact of hospital interventions on 
mortality and reductions in caesarean deliveries relative to anticipated 
levels. The collection and publication of data involved in this programme 
provides an innovative example of the kind of information that policy 
makers and consumers ought to have available to assess the quality of care. 
The reputational effects of this data alone may be a strong impetus for 
hospital managers to improve performance, particularly in Korea‟s highly 
competitive hospital market. However, in the absence of a formal 
evaluation, it is difficult to judge the extent to which the pay-for-
performance programme has driven improved performance, or on the 
contrary merely mimicked a trajectory of gradually improving performance 
that existed prior to the introduction of the scheme. The study of the US 
programme on which Korea modelled this scheme suggests that the 
introduction of pay–for-performance led to an improvement in quality 
outcomes amongst participating hospitals relative to their peers, but that 
differences dissipated after five years. This is consistent with other 
international evidence suggesting that targeted pay-for-performance 
schemes can help drive improvements over a specified period. Furthermore, 
it is unclear whether the pay-for-performance scheme incentivises activity 
without the adverse effects of leading providers to modify behaviour to 
maximise payments. For this reason, the Korean balance of modest financial 
incentives and a strong focus on data collection may be the virtue of this 
programme. 
Improving care for cardiovascular diseases 
There is a paradox in quality of care outcomes for cardiovascular 
conditions in Korea 
Quality indicators for cardiovascular care paint an interesting paradox in 
Korea when compared with other OECD countries. In general, Koreans are 
less likely to die from acute myocardial infarction (AMI), but those Korean 
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patients who are admitted to hospital for AMI are likely to face amongst the 
highest case-fatality rates amongst OECD countries. At the same time, 
Koreans are more likely to die of stroke than those in many other OECD 
countries, but fatalities from stroke once in hospital, are much lower in 
Korea compared with other OECD countries – in hospital 30-day case 
fatality rates are 1.2 per 100 patients compared with an OECD average of 
5.2 per 100 patients. 
In most OECD countries, in-hospital fatality rates across the two acute 
manifestations of underlying vascular conditions – AMI and stroke – are 
both either relatively good, or relatively bad. For example, Denmark, 
Norway and the United States report amongst the lowest rates of OECD 
countries for both conditions. Population-based mortality trends also tend to 
be similar – they are either good or bad across the two conditions. 
Furthermore, countries with high population-based mortality rates will also 
often have high case-fatality rates, though care is needed in inferring that 
high case-fatality rates in hospitals are a principle cause of high population-
based mortality rates.
1
 
However, this Korean paradox suggests there are two issues around the 
quality of cardiovascular care in Korea. The first is whether the high case-
fatality rates reflect poor quality hospital care. Trends in OECD countries 
have shown an overall decline in case-fatality rates over the past ten years, 
suggesting quality improvements in acute care delivery can make a 
difference. The second is whether policies to reduce cardiovascular disease 
outside the hospital sector are being delivered appropriately. 
Acute care is usually delivering high-quality cardiovascular care, 
but there are variations in quality across the country 
It is unlikely that the divergence in in-hospital case-fatality rates for 
cardiovascular care (notably AMI mortality rates) reflects bad performance 
in Korean hospitals. The Korean Government‟s review of care quality for 
cardio- and cerebro-vascular diseases (CVD), as well as performance data 
collected by both HIRA and the Korean Centre for Disease Control 
(KCDC), suggests that quality of care for AMI and stroke in hospitals is 
amongst the best in OECD countries. After arrival to the appropriate 
hospital unit, care delivered in Korea is likely to be consistent with clinical 
guidelines and best practices in other OECD countries. This is demonstrated 
by good performance in process indicators such as the administration of 
aspirin upon arrival to the hospital and appropriate prescriptions at the time 
of discharge in the case of AMI. While the volume and capacity of acute and 
elective cardio-vascular interventions such as PCI‟s and CABGs has been 
increasing significantly over the past few years in Korea, a clear relation 
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between volumes and patient outcomes is difficult to establish. These 
indicators of performance and recent capacity expansions suggest that 
neither low capacity, nor poor processes are likely explanations of high in-
hospital case-fatality rates for AMI relative to other countries.  
Instead, the most plausible explanation of the apparently poor 
performance of acute care for AMI is actually a failure in the non-acute care 
sectors. The case mix of patients presenting to Korean hospitals is likely to 
be characterised by advanced stages of AMI and more complex conditions. 
Consistent with this review‟s major conclusion of an underdeveloped 
primary care system, it is likely that insufficient care and support provided 
outside hospitals (in primary care for prevention and in post-acute 
rehabilitation) is the cause of poorer hospital outcomes. This is likely to be 
reinforced by the absence of cardiac rehabilitation services leading to a 
higher numbers of readmitted patients. 
The contrast between high-quality hospital care and weaker out-of-
hospital care for CVD reflects policy. While the government has had a 
proactive strategy to improve quality of care for CVD through strengthening 
prevention and in-hospital care, more effort has been directed at assisting 
certain hospitals in adopting best-practice care delivery models for CVD. 
The Korean government‟s Comprehensive Plan for CVD is the major 
national policy that seeks to drive improvements in the quality of care for 
cardiovascular conditions, most notably though advocating for the creation 
of regional cardiovascular centres. Ideally, these centres ought to serve as 
vertical institutions offering services ranging from health promotion (with 
tailored consultations with a specialised physicians) to care in the acute 
phase and rehabilitation. However, in implementation most of the financial 
assistance to designated regional centres has been directed at new services 
(such as 24-hour emergency stroke units) or operation and maintenance 
costs associated with acute CVD care. Investments in the prevention and 
health promotion work streams are more marginal. 
Only a selected number of institutions have received financial and 
technical assistance to develop stroke units and enhanced facilities under 
Korea‟s Comprehensive Plan for CVD. Efforts have been made to support 
hospitals located outside of Seoul: nine institutions (including three 
university hospitals) have been designated as regional centres since 2008. 
While this has helped to create pockets of excellence, it has not made 
significant progress in improving the quality of cardiovascular care across 
the acute care sector at large. While they have often invested in high-
technology medical equipment, many Korean hospitals have not established 
stroke units, which are a comparatively simple innovation that can make a 
substantial difference in improving the quality of CVD care. Today, half of 
tertiary hospitals and 90% of general hospitals do not have stroke units. 
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Furthermore, given the broad dispersion of those living in rural areas across 
the country, the small number of centres that have benefited from the 
comprehensive plan for CVD is unlikely to have made major progress in 
helping reduce significant disparities that exist between rural and urban 
areas. For most people living in rural areas, whether their closest hospital 
happens to be equipped with a stroke facility (and/or other acute cardio-
vascular intervention facilities) is likely to be a major determinant in the 
quality of their acute cardiovascular care. Efforts should be undertaken to 
rebalance the focus of financial investments away from equipping a small 
number of hospitals with very sophisticated technologies towards 
establishing care pathways for acute cardio-vascular conditions and stroke 
units across the system at large. This would help address inequalities 
between regions and between tertiary and general hospitals. 
Pre- and post- acute care should be the focus of improving quality 
of care for cardiovascular diseases  
Improving cardiovascular care outside of hospitals ought to be the 
policy priority to help improve cardiovascular care outcomes for Koreans. 
The Korean population is currently experiencing substantial changes in 
lifestyles, such as an increased consumption of trans-fats and salts, which 
presage likely future rises in the prevalence of particular chronic conditions 
relevant to CVD. Korea also has one of the most rapidly ageing populations, 
with the proportion of those aged 65 among the total population projected to 
reach 37% by 2050 (today, the share of those aged 65 and older is 11% of 
the total population). With the principal risk factor for CVD being older age 
– even in the absence of symptoms or very high levels of hypertension, 
diabetes and smoking – this is likely to drive an increase in the prevalence of 
CVD across Korea. 
Focusing on prevention and proactive primary care services to modify 
these risky lifestyle behaviours and support patients in managing their health 
would help reduce the burden of cardiovascular conditions (and the burden 
of diabetes) in the future. Current prevention policies in Korea mainly 
revolve around two screening programmes organised by the National Health 
Insurance Corporation and the Ministry of Health and Welfare. While this 
forms a solid basis for identifying patients, there is a need to build on these 
programmes by establishing formal mechanisms to help coordinate care and 
deliver case management to those patients at risk in the long run. Korea 
ought to consider establishing registration for patients at risk as part of 
broader efforts to strengthen primary care (as noted above). A select few 
initiatives, such as those in Daegu city and Gwang Meong-si, have 
demonstrated the capability to help organise health care in a patient-centered 
way and secure high levels of satisfaction amongst both patients and 
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medical professionals. The success of these programmes lies in regular 
monitoring of risk factors to help patients avoid a general deterioration of 
health prior to hospital admission. 
Supplementing this, efforts ought to be made to minimise intervention 
time and the lag between the onset of a stroke or AMI and the arrival of a 
patient to hospitals. An evaluation of ambulance services details high 
reported times – of up to six hours – between the onset of AMI and stroke 
and arrival in hospital and pointed to the need to act on two key challenges. 
Firstly, to raise public and patient awareness in identifying the onset of a 
stroke and AMI and seeking care rapidly. Secondly, to enhance the quality 
and responsiveness of ambulance services (especially in rural areas) that 
could help ensure that therapeutic interventions such as thrombolysis (when 
indicated) is performed more quickly, thereby offering patients a higher 
chance of survival.  
Establishing formal rehabilitation processes for AMI and stroke would 
also be a high value-for-money investment in Korea. Providing 
comprehensive rehabilitation care is fundamental to the recovery of patients 
who have suffered a heart attack, a coronary artery bypass graft operation or 
a stroke. By assisting patients in exercise, education and psycho-social 
health, rehabilitation can help prevent secondary complications, reduce 
mortality and improve patients‟ health outcomes. Rehabilitation care in 
Korea is supported by two avenues: National Health Insurance provides 
funding for stays in long-term care hospitals (which mainly provide sub-
acute care) and long-term care insurance supports extended stays in long-
term care facilities for patients assessed to have ongoing care needs. In 
general, rehabilitation care in Korea is at an early stage of development and 
there are few institutional facilities that provide rehabilitation services 
exclusively for patients who have survived an AMI or stroke. The recent 
growth of long-term care hospitals is a welcome development in helping 
expand these critical services. Policy makers should consider building on 
this by seeking to support community-based rehabilitation (especially home 
care services for patients who have to live with the consequences of a 
stroke) as part of National Health Insurance and not simply for the smaller 
group of people that have long-term care insurance. Community-based 
rehabilitation services are often able to be delivered more cheaply than in a 
hospital setting, which may also help make them more financially accessible 
to patients discouraged by high out-of-pocket costs. This represents a value-
for-money investment in improving cardiovascular care in Korea. It will 
help reduce readmission rates and holds the potential to reduce unnecessary 
expenditure on expensive cardiac interventions 
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Concluding remarks 
The strengths and weaknesses in the quality of cardiovascular care in 
Korea mirror those of the Korean health care system at large. In Korea‟s 
substantial achievement of expanding health coverage over the past two 
decades, value for money has often been secondary to health care industry 
development. This has delivered world-class hospitals to the bulk of the 
population (those in major cities), but has also entrenched the primacy of 
acute care in the Korean health care system.  
The Korean experience provides some important lessons to other 
countries, both those of the OECD and other middle income countries 
seeking to deliver universal health coverage. Foremostly, strong budgetary 
controls are important. Without budget constraints or regulation on supply, 
the well-organised hospital sector can quickly come to dominate health 
services delivery at the expense of quality. Secondly, Governments ought 
take early action to develop primary care infrastructure and entrench gate-
keeping by primary care professionals as a norm in the health system. 
Lastly, Governments and insurers should demand accountability for – and 
improvements in – the quality of care for the substantial payments they 
make to health care providers.  
 Korea‟s challenges are not unique – most OECD countries are 
grappling with reorienting their health care systems towards enhancing cost-
effective primary care and preventive health services that support people in 
making good lifestyle decisions, living healthier lives and avoiding visits to 
hospitals. However, the tendency for over-delivery of hospitals services is 
now so entrenched in the Korean health care system that Korea faces 
increases in health care costs that outpace its OECD counterparts.  
Korea is fortunate to be able to face this challenge from a position of 
lower overall levels of spending, but must act to ensure that additional 
health care spending goes to the right places. This report argues that 
transitioning to a health care system that is better placed to deliver high-
quality care into the future will require a continued focus in three areas: 
building a stronger community-based primary care system; using 
information to target services more effectively and assess whether taxpayers 
are receiving value for money; and re-orienting the focus of policy making 
to deliver continued improvements in health, not just health insurance. 
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Policy recommendations for improving the quality of care 
in the Korean health system 
The challenge for the Korean health system over coming years will be to shift its focus towards 
supporting the rising number of people living with chronic disease and multiple morbidities. To 
achieve this, quality of care should be embedded as a key objective of further reforms. This will 
require changes to: 
1. Improve governance and quality of care strategies by: 
 Establishing systems to monitor individual clinician performance to identify 
undesirable events such as breaches in patient safety. This should be complemented 
with a means for patients to provide feedback of their experience of health care services 
and report medical errors. 
 Seeking that medical professional associations investigate quality breaches and 
professional misconduct, including recommending de-registration to the Minister for 
Health and Welfare in instances of serious misconduct.  
 Requiring that general and small hospitals undertake accreditation and continuing to 
expand accreditation into long-term care hospitals, as well as establish a programme for 
the accreditation of primary care facilities.  
 Bolstering the development of clinical practice guidelines and establishing a process by 
which guidelines can influence financing decisions. 
 Making the most of the Drug Utilisation Review by checking for compatibility amongst 
therapeutic groups, and over time, expanding it to include drugs delivered in major 
hospitals.  
 Better utilising available data to analyse the performance of the health system and tailor 
care to the needs of patients. For example, HIRA should provide information on patient 
outcomes and services on a regional level, to assess if resources are being directed 
appropriately. 
 Building a simple electronic patient history, using information and technology already 
available to HIRA and by working to accommodate privacy concerns. 
 Establishing HIRA as an institutional champion for quality of care in the Korean health 
system that is responsible for assuring the quality of all health care services (including 
those not covered by insurance), provides feedback to individual providers and 
publishes information for consumers.  
2. Strengthen primary care‟s capacity to prevent disease and support those suffering from 
chronic conditions by: 
 Making the development of a community-based, family-medicine sector the foremost 
investment priority in the Korean health care system.  
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 Directing the bulk of new investment towards scaling-up effective models of primary 
care by specifying “best-practice characteristics” and supporting regional providers 
who can accord with these characteristics in meeting local health needs. Where 
appropriate, this should build on existing infrastructure for screening services across 
Korea and encourage the adoption of group practice. 
 Using financial investments in primary care to support the long-term establishment of a 
regional architecture for primary care that can help National Health Insurance agencies 
identify and direct funding to areas most at need. 
 Developing better measures of quality of care in primary care to guide policy 
development and funding, including regional assessments of needs and shortfalls. 
 Establishing a mandatory training rotation in a primary-care facility as part of medical 
education in Korea, and considering a modest training subsidy to support such a 
programme. 
 Expanding the number of advanced practice nurses and better utilising their skills in 
working with physicians to deliver primary care services. 
 Investigating methods to further encourage controlled and appropriate referrals by 
primary care professionals. 
3. More effectively use financing to drive improvements in quality of care by: 
 Expanding DRG-based financing across the entire Korean hospitals sector and across 
as many services categories as clinically feasible. 
 Complementing DRG-based financing with appropriate admissions and discharge 
criteria, quality measures such as present-on-admission flags and close surveillance of 
the volume and mix of services being delivered.  
 Better embedding quality into purchasing over time by giving National Health 
Insurance agencies a greater mandate to design payment structures and to customise 
payments to hospitals on the basis of improving quality or efficiency outcomes. 
 Using DRG payments to consider specifying an overall budget for hospital services. 
This should be supported by credible penalties for overruns and in the long term, be 
used to influence the allocation of funds between acute and primary care.  
 Making investments to scale up primary care a distinct component of National Health 
Insurance expenditure, and consider the hypothecation of a gradually increasing 
proportion of revenues towards this purpose over time. 
 Increasing financial support for primary care services to support prevention and patient 
self management of chronic disease (such as physician education and counselling), and 
reduce the reliance on minor surgical procedures, diagnostic tests and prescribing as a 
source of income.  
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 Redirecting current incentives, which increase fee-for-service payment by the size of 
hospital, towards rewarding hospitals on the basis of the quality of care they deliver.  
 Piloting the use of “bundled payments” that prospectively combine payment for a 
hospital admission as well as a reasonable number of pre and post-admission services, 
to encourage hospitals to invest in less clinically intensive rehabilitation services. 
 Formally evaluate the Value Incentive Programme to inform the further use of pay-for-
performance to improve the quality of care in targeted areas on an intermittent basis.  
 Improving transparency in the Korean hospital sector by reporting services not 
reimbursed by insurance to government and strengthening financial disclosure 
obligations on major hospitals. 
4. Improving the quality of care for cardiovascular diseases by:  
 Undertaking greater investment in promoting good health and preventing 
cardiovascular diseases. 
 Rebalancing the focus of investment away from equipping a small number of hospitals 
with sophisticated technologies and towards establishing cardiovascular critical-care 
pathways and stroke units across the system at large. 
 Establishing registration for patients at risk in order to deliver regular monitoring 
services and follow-up services. 
 Raising public and patient awareness in identifying the onset of a stroke and AMI in 
order to seek care rapidly. 
 Enhancing the quality and responsiveness of ambulance services (especially in rural 
areas). 
 Expanding rehabilitation capacity in the Korean health system, including through 
community-based rehabilitation by a broad range of health professionals. 
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Note
 
1.  Population-based mortality is an indication of overall population health, 
dependent on social and economic health determinants, preventive care 
and access to secondary care. While case-fatality rates are intended to 
indicate the quality of hospital care – hospitals admitting a higher 
proportion of complex and more advanced disease cases will, possibly, 
have worse outcomes. In the absence of a proper international method for 
adjusting for differences in case mix, it is difficult to make robust 
international comparisons. 
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